Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1b/2 study of the liposomal formulation of eribulin (E7389-LF) in combination with nivolumab: Results from the phase 2 esophageal cancer cohort.
Oshima T, Yamamoto S, Kawakami H, Makino T, Kawazoe A, Masuishi T, Tsushima T, Hirao M, Tsuda M, Hino K, Yamamoto N, Hara H, Kaname S, Matsuoka D, Otake Y, Yasuda K, Takase T, Takashima S, Semba T, Ooki A. Oshima T, et al. Among authors: yasuda k. BJC Rep. 2024 Sep 4;2(1):66. doi: 10.1038/s44276-024-00066-6. BJC Rep. 2024. PMID: 39516370 Free PMC article.
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.
Kawazoe A, Yamamoto N, Sugimoto N, Kawakami H, Oshima T, Yamaguchi K, Hino K, Hirao M, Kurokawa Y, Kawakami T, Tsuda M, Hara H, Kaname S, Matsuoka D, Otake Y, Yasuda K, Takase T, Takashima S, Semba T, Muro K. Kawazoe A, et al. Among authors: yasuda k. Clin Cancer Res. 2024 Apr 1;30(7):1264-1272. doi: 10.1158/1078-0432.CCR-23-1768. Clin Cancer Res. 2024. PMID: 38295160 Free PMC article. Clinical Trial.
De novo generation of dual-target compounds using artificial intelligence.
Yasuda K, Berenger F, Amaike K, Ueda A, Nakagomi T, Hamasaki G, Li C, Otani NY, Kaitoh K, Tsuda K, Itami K, Yamanishi Y. Yasuda K, et al. iScience. 2024 Dec 17;28(1):111526. doi: 10.1016/j.isci.2024.111526. eCollection 2025 Jan 17. iScience. 2024. PMID: 39801837 Free PMC article.
Approaches for difficult-to-induce-seizures electroconvulsive therapy cases (DEC): a Japanese expert consensus.
Takekita Y, Suwa T, Yasuda K, Kawashima H, Omori W, Kurimoto N, Tsuboi T, Noda T, Aoki N, Wada K, Inada K, Takebayash M; Expert Consensus Development Working Group; Electroconvulsive Therapy Committee; Japanese Society of General Hospital Psychiatry. Takekita Y, et al. Among authors: yasuda k. Ann Gen Psychiatry. 2025 Jan 12;24(1):2. doi: 10.1186/s12991-024-00543-9. Ann Gen Psychiatry. 2025. PMID: 39800695 Free PMC article.
Development and validation of an algorithm for identifying patients undergoing dialysis from patients with advanced chronic kidney disease.
Imaizumi T, Yokota T, Funakoshi K, Yasuda K, Hattori A, Morohashi A, Kusakabe T, Shojima M, Nagamine S, Nakano T, Huang Y, Morinaga H, Ohta M, Nagashima S, Inoue R, Nakamura N, Ota H, Maruyama T, Gobara H, Endoh A, Ando M, Shiratori Y, Maruyama S. Imaizumi T, et al. Among authors: yasuda k. Clin Exp Nephrol. 2025 Jan 6. doi: 10.1007/s10157-024-02614-3. Online ahead of print. Clin Exp Nephrol. 2025. PMID: 39762534
3,738 results